2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
39
Colonic Neoplasms
14
Colorectal Neoplasms
13
Neoplasms
12
Rectal Neoplasms
11
Prostatic Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Uterine Cervical Neoplasms
8
Obesity
8
Motor Activity
8
Lung Neoplasms
8
Endometrial Neoplasms
8
Tobacco Use Disorder
6
Small Cell Lung Carcinoma
6
Overweight
6
Depression
6
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Leukemia, Myeloid, Acute
5
Fatigue
5
Breast Carcinoma In Situ
5
Anxiety Disorders
5
Urinary Bladder Neoplasms
4
Sexuality
4
Sexual Dysfunction, Physiological
4
Leukemia
4
Head and Neck Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Intraductal, Noninfiltrating
4
Body Weight Changes
4
Interventions
palbociclib
1
exemestane
1
delta 24-sterol reductase
1
Vinorelbine
1
Therapeutics
1
Tamoxifen
1
Standard of Care
1
Risk Assessment
1
Paclitaxel
1
Letrozole
1
Influenza Vaccines
1
Fulvestrant
1
Focus Groups
1
Epirubicin
1
Drug Therapy
1
Counseling
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Patient Acceptance of Health Care
×
Counseling
×
Clear all
NCT05834933
2023-08-03
NBCRS
University of Ibadan
Phase NA
Completed
719 enrolled